Laurence Leysen

TL;DR: The available evidence supports various pharmacological and non-pharmacological strategies to reduce central sensitisation and to improve patient outcomes in several conditions commonly seen in rheumatology practice and studies suggest the possibility of matching non-Pharmacological approaches, or medications, or both to thecentral sensitisation pain phenotypes.

TL;DR: The current understanding of insomnia is applied to clinical practice, including assessment and conservative treatment of insomnia in people with chronic pain.

TL;DR: The treatment rationale based on the complex mechanisms underlying CS in patients having chronic pain is presented and emphasis is given to explaining the concept of CS when providing treatment, as well as why patients and clinicians should focus on long-term rather than short-term treatment effects.

TL;DR: The International Association for the Study of Pain (IASP) released clinical criteria and a grading system for nociplastic pain affecting the musculoskeletal system as mentioned in this paper.

TL;DR: BMI > 30, education < 12–13 years, lymphedema, not smoking, axillary lymph node dissection, chemotherapy, hormone therapy, and radiotherapy were significantly associated with higher odds for the development of chronic pain, with lympherema being the biggest risk factor.